Trial Profile
Comparison of ropivacaine versus ropivacaine + dexmedetomidine on the onset and resolution of sensory block in volunteers undergoing posterior tibial ultrasound-guided nerve sensory block
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2012
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Ropivacaine
- Indications Postoperative pain
- Focus Pharmacodynamics
- 30 Aug 2012 New trial record
- 23 Jul 2012 Results published in Anesthesia and Analgesia.